These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7923858)

  • 1. The apolipoprotein C-II variant apoC-IILys19-->Thr is not associated with dyslipidemia in an affected kindred.
    Zysow BR; Pullinger CR; Hennessy LK; Farese RV; Ghassemzadeh M; Kane JP
    Clin Genet; 1994 Jun; 45(6):292-7. PubMed ID: 7923858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel apolipoprotein C-III variant, apoC-III(Gln38-->Lys), associated with moderate hypertriglyceridemia in a large kindred of Mexican origin.
    Pullinger CR; Malloy MJ; Shahidi AK; Ghassemzadeh M; Duchateau P; Villagomez J; Allaart J; Kane JP
    J Lipid Res; 1997 Sep; 38(9):1833-40. PubMed ID: 9323592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning and characteristics of a new apolipoprotein C-II mutant identified in three unrelated individuals with hypercholesterolemia and hypertriglyceridemia.
    Pullinger CR; Zysow BR; Hennessy LK; Frost PH; Malloy MJ; Kane JP
    Hum Mol Genet; 1993 Jan; 2(1):69-74. PubMed ID: 8490626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and metabolic characteristics of an apolipoprotein C-II variant isolated from a hypertriglyceridemic subject.
    Huff MW; Evans AJ; Wolfe BM; Connelly PW; Maguire GF; Strong WL
    J Lipid Res; 1990 Mar; 31(3):385-96. PubMed ID: 2341805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45-->Asn), in a Turkish patient.
    Lüttmann S; von Eckardstein A; Wei W; Funke H; Köhler E; Mahley RW; Assmann G
    J Lipid Res; 1994 Aug; 35(8):1431-40. PubMed ID: 7989867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a novel human apolipoprotein (apoC-IV) causes hypertriglyceridemia in transgenic mice.
    Allan CM; Taylor JM
    J Lipid Res; 1996 Jul; 37(7):1510-8. PubMed ID: 8827523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning of a human apoC-III variant: Thr 74----Ala 74 mutation prevents O-glycosylation.
    Maeda H; Hashimoto RK; Ogura T; Hiraga S; Uzawa H
    J Lipid Res; 1987 Dec; 28(12):1405-9. PubMed ID: 3123586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of guar gum on plasma lipoproteins and apolipoproteins C-II and C-III in patients affected by familial combined hyperlipoproteinemia.
    Bosello O; Cominacini L; Zocca I; Garbin U; Ferrari F; Davoli A
    Am J Clin Nutr; 1984 Dec; 40(6):1165-74. PubMed ID: 6095636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A deletion mutation in the ApoC-II gene (ApoC-II Nijmegen) of a patient with a deficiency of apolipoprotein C-II.
    Fojo SS; Stalenhoef AF; Marr K; Gregg RE; Ross RS; Brewer HB
    J Biol Chem; 1988 Dec; 263(34):17913-6. PubMed ID: 3192518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel type hypertriglyceridemia observed in FLS mice.
    Takahashi M; Saibara T; Nemoto Y; Ono M; Akisawa N; Iwasaki S; Toda K; Ogawa Y; Wakatsuki A; Inagaki S; Onishi S
    Lipids; 2003 Jul; 38(7):687-92. PubMed ID: 14506831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide.
    Sakurai T; Sakurai A; Vaisman BL; Amar MJ; Liu C; Gordon SM; Drake SK; Pryor M; Sampson ML; Yang L; Freeman LA; Remaley AT
    J Pharmacol Exp Ther; 2016 Feb; 356(2):341-53. PubMed ID: 26574515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on apoE gene polymorphism in Chinese type II b hyperlipidemia].
    Zhang X; Bai H; Liu B; Fan P; Zhang R; Xu Y; Yao J; Zhu H
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):179-82. PubMed ID: 12600078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoC-IIParis2: a premature termination mutation in the signal peptide of apoC-II resulting in the familial chylomicronemia syndrome.
    Parrott CL; Alsayed N; Rebourcet R; Santamarina-Fojo S
    J Lipid Res; 1992 Mar; 33(3):361-7. PubMed ID: 1569385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr.
    Liu H; Labeur C; Xu CF; Ferrell R; Lins L; Brasseur R; Rosseneu M; Weiss KM; Humphries SE; Talmud PJ
    J Lipid Res; 2000 Nov; 41(11):1760-71. PubMed ID: 11060345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an apoC-II variant (apoC-IIBethesda) in a kindred with apoC-II deficiency and type I hyperlipoproteinemia.
    Sprecher DL; Taam L; Gregg RE; Fojo SS; Wilson DM; Kashyap ML; Brewer HB
    J Lipid Res; 1988 Mar; 29(3):273-8. PubMed ID: 3379339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E.
    Xu Y; Berglund L; Ramakrishnan R; Mayeux R; Ngai C; Holleran S; Tycko B; Leff T; Shachter NS
    J Lipid Res; 1999 Jan; 40(1):50-8. PubMed ID: 9869649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of apo C-II and apo C-III in very low density lipoproteins of normal and type IV subjects.
    Catapano AL
    Atherosclerosis; 1980 Apr; 35(4):419-24. PubMed ID: 7378122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.